Skip to content

Development of a Herbal Balm Containing Ginger Essential Oil for Relief of Muscle Pain in Patients with Office Syndrome

Development of a Herbal Balm Containing Ginger Essential Oil for Relief of Muscle Pain in Patients with Office Syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260520006
Enrollment
80
Registered
2026-05-20
Start date
2026-01-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Pain in Patients with Office Syndrome Essential oil, Diclofenac gel, Herbal balm, Office syndrome, Randomized controlled trial, Zingiber officinale

Interventions

Apply 1-2 g. to the affected area twice daily (morning &amp
evening) for 4 weeks.,Apply 1-2 g. to the affected area twice daily (morning &amp
evening) for 4 weeks.
Active Comparator Drug,Active Comparator Drug
Control group (1% Diclofenac Gel),Experimental group (Ginger Balm Group)

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1 Male or female participants aged between 20-60 year 2 Participants experiencing pain and muscle stiffness in the neck, shoulders, scapular area, and upper back caused by continuous repetitive work for 4 weeks. 3 Participants with moderate pain intensity scores ranging from 4-6 points assessed by the Numerical Analog Scale. 4 Participants must not have any diseases or contraindications to medication use, such as wounds, inflammation, or a history of injury to the neck, shoulders, scapular area, or upper back. 5 Participants must refrain from using NSAIDs, anti- inflammatory drugs, and analgesics for at least 4 hours prior to participation in the study. 6 Participants must be able to communicate without communication limitations and have accessible communication channels, such as a telephone number or the LINE application. 7 Participants must have no history of allergy to ginger, ginger essential oil, or diclofenac gel. 8.Participants were willing to participate voluntarily in the research project and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1 Pain caused by neurological or musculoskeletal disorders, such as radiculopathy, myelopathy, or severe herniated disc compression. 2 Participants who received additional pain-relief medications from pharmacies or healthcare facilities during the study period. 3 Participants who had received steroid injections, physical therapy procedures, or continuous acupuncture treatment (dry needling) within the past 2 months.

Design outcomes

Primary

MeasureTime frame
Pain score at 2 week, 4 week. Numerical Rating Scale,Cervical Range of Motion (CROM) at 2 week, 4 week. Goniometer

Secondary

MeasureTime frame
Satisfaction at 4 week Satisfaction Questionnaire,General characteristics, Color & scent, Usability

Countries

Thailand

Contacts

Public ContactRatchadawan Aukkanimart

Rajamangala University of Technology Isan

Ratchadawan.au@Rmuti.ac.th0854611959

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026